Leydig cell tumor and malignant lymphoma in a patient with nonclassical 21-hydroxylase deficiency

8Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A 46-year-old man was admitted in our hospital with hypoglycemia; his FPG was 43 mg/mL. Five years earlier, he underwent simultaneous surgeries for an adrenal adenoma, a benign Leydig cell tumor (LCT), and a malignant lymphoma. Based on the laboratory results, he was diagnosed as congenital adrenal hyperplasia (CAH) due to nonclassical 21-hydroxylase deficiency (21-OHD). On immunohistochemistry analysis using the antibody against adrenal-specific 11β-hydroxylase antibody, the LCT showed both properties as a testicular cell and as an adrenal cell. The genetic background of 21-OHD might contribute to the development of malignant lymphoma. Such as a case of LCT and malignant lymphoma in a patient with 21-OHD seems to be rare. © 2009 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Inaba, H., Suzuki, S., Shigematsu, S., Shinomiya, K., Ohfusa, H., Shimojo, Y., … Hashizume, K. (2009). Leydig cell tumor and malignant lymphoma in a patient with nonclassical 21-hydroxylase deficiency. Internal Medicine, 48(8), 601–605. https://doi.org/10.2169/internalmedicine.48.1733

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free